References
- BEAUMONT, K., HARPER, A., SMITH, D. and BENNETT., J., 2000, The role of P-glycoprotein in determining the oral absorption and clearance of the NK2 antagonist, UK-224,671. European Journal of Pharmaceutical Science, 12, 41–50.
- BOOLELL, M., GEPI-ATTEE, S., GINGELL, J. C. and ALLEN, M. J., 1996, Sildenafil, a novel effective treatment for male erectile dysfunction. British Journal of Urology, 78, 257–261.
- DRUECKES, P., SCHINZEL, R. and PALM, D., 1995, Photometric microtiter assay of inorganic phosphate in the presence of acid labile organic phosphates. Analytical Biochemistry, 230, 173–177.
- FARDEL, O., LECUREUR, V. and GunLouzo, A., 1996, The P-glycoprotein multidrug transporter. General Pharmacology, 27, 1283–1291.
- GRAMATTE, T., °ERTEL, R., TERHAAG, B. and KIRCH, W., 1996, Direct demonstration of small intestinal secretion and site-dependent absorption of the O-blocker talinolol in humans. Clinical Pharmacology and Therapeutics, 59, 541–549.
- HEBERT, M. F., 1997, Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Advanced Drug Delivery Reviews, 27, 201–214.
- HUNTER, J. and HIRST, B. H., 1997, Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Advanced Drug Delivery Reviews, 25, 129–157.
- KAYE, B., HERRON, W. J., MACRAE, P. V., ROBINSON, S., STOPHER, D. A., VENN, R. F. and WILD, W., 1996, Rapid, solid phase extraction technique for the high-throughput assay of darifenacin in human plasma. Analytical Chemistry, 68, 1658–60.
- LIPINSKI, C. A., LOMBARDO, F., DOMINY, B. W. and FEENEY, P. J., 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3–25.
- LOWN, K. S., MAYO, R. R., LEICHTMAN, A. B., HSIAO, H.-L., TURGEON, D. K., SCHMEIDLIN-REN, P., BROWN, M. B., Guo, W., Rossi, S. J., BENET, L. Z. and WATKINS, P. B., 1997, Role of intestinal P-glycoprotein (mdrl) in interpatient variation in the oral bioavailability of cyclosporine. Clinical Pharmacology and Therapeutics, 62, 248–260.
- SANDSTROM, R., KARLSSON, A., KNUTSON, L. and LENNERNAS, H., 1998, Jejunal absorption and metabolism of R/S-verapamil in humans. Pharmaceutical Research, 15, 856–862.
- SANDSTROM, R., KNUTSON, T. W., KNUTSON, L., JANSSON, B. and LENNERNAS, H., 1999, The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans. British Journal of Clinical Pharmacology, 48, 1 80–189.
- SARKADI, B., PRICE, E. M., BOUCHER, R. C., GERMANN, U. A. and SCARBOROUGH, G. A., 1992, Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. Journal of Biological Chemistry, 267, 4854–4858.
- SHAPIRO, A. B. and LING, V., 1998, The mechanism of ATP-dependent multidrug transport by P-glycoprotein. Acta Physiologica Scandinavia, 163, 227–234.
- SPAHN-LANGGUTH, H., BAKTIR, G., RADSCHUWETP, A., OKYAR, A., TERHAAG, B., ADER, P., HANAFY, A. and LANGGUTH, P., 1998, P-glycoprotein transporters and the gastrointestinal tract: Evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound. International Journal of Clinical Pharmacology and Therapeutics, 36, 16–24.
- WALLIS, R. M., CORBIN, J. D., FRANCIS, S. H. and Ews, P., 1999, Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. American Journal of Cardiology, 83, 3C–12C.
- WANG, E.-J., CASCIANO, C. N., CLEMENT, R. P. and JOHNSON, W. W., 2000, In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. Drug Metabolism and Disposition, 28, 522–528.